Join Growin Stock Community!

Haoxi health technology limitedHAO.US Overview

US StockCommunication Services
(No presentation for HAO)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

HAO AI Insights

HAO Overall Performance

HAO AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

HAO Recent Performance

-13.95%

Haoxi health technology limited

-0.87%

Avg of Sector

-0.31%

S&P500

HAO PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

HAO Key Information

HAO Financial Forecast

chart

Browsing restrictions can be lifted for a fee.

QuarterlyEPS ForecastQoQMaxMin
2026Q1
2026Q2
2026Q3
2026Q4
2027Q1

HAO Profile

Haoxi Health Technology Limited, through its subsidiaries, provides online marketing solutions in China. It offers online marketing solutions, including online short video marketing solutions to advertisers through its media partners; and customized marketing solutions by planning, producing, placing, and optimizing online ads to help advertisers acquire, convert, and retain consumers on various online media platforms. The company places its ads through mainstream online short video and social media platforms, such as Toutiao, Douyin, WeChat, and Sina Weibo. It serves advertiser client base primarily in the healthcare industry. The company was founded in 2018 and is based in Beijing, China.

Price of HAO

HAO FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

HAO Earnings Table

Unit : USD

QTRNon-GAAP EPSEPS YoYEPS Surprise %SalesSales YoYSales Surprise %NPM
Current
2025Q4
2025Q3
2025Q2
2025Q1
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-0.06
PE Ratio (TTM)
0.97
Forward PE
-
PS Ratio (TTM)
2.33
PB Ratio
4.40
Price-to-FCF
-
METRIC
VALUE
vs. INDUSTRY
Gross Margin
2.01%
Net Margin
-0.97%
Revenue Growth (YoY)
-2.17%
Profit Growth (YoY)
-52.65%
3-Year Revenue Growth
37.76%
3-Year Profit Growth
-13.03%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-0.06
PE Ratio (TTM)
0.97
Forward PE
-
PS Ratio (TTM)
2.33
PB Ratio
4.40
Price-to-FCF
-
Gross Margin
2.01%
Net Margin
-0.97%
Revenue Growth (YoY)
-2.17%
Profit Growth (YoY)
-52.65%
3-Year Revenue Growth
37.76%
3-Year Profit Growth
-13.03%

  • When is HAO's latest earnings report released?

    The most recent financial report for Haoxi health technology limited (HAO) covers the period of 2024Q4 and was published on 2024/06/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating HAO's short-term business performance and financial health. For the latest updates on HAO's earnings releases, visit this page regularly.

  • How much debt does HAO have?

    As of the end of the reporting period, Haoxi health technology limited (HAO) had total debt of 1.23M, with a debt ratio of 0.07. Short-term debt comprises a higher/lower proportion. The level of financial leverage directly impacts the company's capital structure and interest coverage. If debt is high, pay attention to interest expenses and refinancing risks. Conversely, a low-leverage structure indicates greater risk tolerance but potentially less growth flexibility.

  • How much cash does HAO have?

    At the end of the period, Haoxi health technology limited (HAO) held Total Cash and Cash Equivalents of 9.1M, accounting for 0.41 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.